Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Harris County: The Complete Guide for Women, Families, and Survivors
As you navigate the aftermath of a breast reconstruction or augmentation procedure that has resulted in unforeseen pain, you deserve a legal team that understands the weight of your experience. At The Manginello Law Firm, PLLC, operating as Attorney911, we recognize that for those of us in the Harris County community, the journey through breast cancer treatment or aesthetic surgery often leads through the esteemed institutions of the Texas Medical Center. However, when the very devices meant to assist in your healing—acellular dermal matrix (ADM), bioabsorbable scaffolds, or surgical mesh—become the source of a new, catastrophic injury, the betrayal feels personal and systemic.
Our managing partner, Ralph P. Manginello, has been a pillar of the Harris County legal community for twenty-seven years. Licensed since November 1998 (Bar Card Number 24007597) and admitted to the United States District Court for the Southern District of Texas, Ralph understands the local medical landscape and the federal doctrinal hurdles that device manufacturers use to shield themselves. We are not just a generalist personal injury firm; we are trial lawyers who currently prosecute high-profile institutional liability cases, such as Bermudez v. Pi Kappa Phi, where we are seeking $10,000,000 for a victim right here in Harris County. We bring that same aggressive, scientific approach to defective medical device litigation.
If you are a resident of Harris County or surrounding areas like Sugar Land, The Woodlands, or Katy, and you have suffered from reconstruction failure, infection, or a malignancy like BIA-ALCL after an implant procedure, we are here to provide the educational depth and legal advocacy you need.
Understanding the Devices: Mesh, ADM, and Scaffolds in Harris County Surgeries
In the world of plastic and reconstructive surgery within Harris County’s medical hubs, three categories of products have become commonplace, often used in what surgeons call the “internal bra” technique. While these products are marketed as essential support structures, many Harris County patients are never told that the FDA has not determined their safety and effectiveness for breast surgery.
Acellular Dermal Matrix (ADM)
Acellular dermal matrix is a biological graft made from human or animal skin that has been processed to remove all cells, leaving behind a connective tissue scaffold. Products like AlloDerm (Allergan/AbbVie), Strattice, and FlexHD are frequently used in Harris County reconstructions to support the weight of a breast implant. However, the FDA’s March 31, 2021 safety communication explicitly warned Harris County healthcare providers about differing complication rates among these products, specifically naming FlexHD (MTF Biologics) and AlloMax (C.R. Bard/BD) as products with significantly higher rates of infection and reoperation.
Bioabsorbable and Resorbable Scaffolds
Unlike permanent mesh, these are synthetic scaffolds designed to be absorbed by your body over time. The most notable in current Harris County litigation is GalaFLEX (Tepha/BD), made of poly-4-hydroxybutyrate (P4HB). While marketed as a temporary support that dissolves in 18 to 24 months, many Harris County women report the scaffold remains palpable and painful for years, leading to chronic inflammation.
Synthetic Surgical Mesh
Occasionally, traditional polypropylene mesh—the kind used in hernia repairs—is used off-label in breast procedures. This material was never intended for the sensitive environment of breast tissue, yet it has been used in Harris County operating rooms, sometimes resulting in tissue erosion and permanent disfigurement.
If you suspect any of these materials contributed to your suffering, call us at 1-888-ATTY-911 for a complete case evaluation.
The FDA Regulatory Landscape: What Harris County Patients Must Know
There is a widespread misconception among Harris County patients that if a device is in an operating room, it must have been “approved” by the FDA for that specific use. The truth is much more complicated and involves a regulatory shortcut known as the 510(k) clearance pathway.
Under 21 USC §360c and 21 CFR Part 807 Subpart E, a device can be cleared for sale if the manufacturer shows it is “substantially equivalent” to a previous “predicate” device. This is not a determination of safety or effectiveness. As established by the Supreme Court in Medtronic v. Lohr, 518 U.S. 470 (1996), 510(k) clearance does not impose the same rigorous federal requirements as Premarket Approval (PMA).
For Harris County women, this means devices like GalaFLEX or Phasix were cleared based on their similarity to older products—sometimes even surgical sutures—without ever being clinically tested in breast tissue. In fact, the FDA’s November 9, 2023 letter to healthcare providers stated verbatim: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
Every major brand used in Harris County today, from AlloDerm to GalaFLEX, reached the market through this 510(k) pathway. Because they were not approved via the PMA process, they do not enjoy the same preemption protections provided by Riegel v. Medtronic. This means Harris County residents have a clear path to hold these manufacturers accountable under state product liability law.
The Spectrum of Complications for Harris County Victims
The impact of a defective scaffold or mesh on a Harris County patient can be life-altering. We recognize that reconstruction failure is not just a medical event; it is a psychological trauma for a cancer survivor.
Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
This is a CD30-positive, ALK-negative T-cell lymphoma that develops in the scar tissue (capsule) around the implant. Historically associated with textured implants like the Allergan BIOCELL (recalled in July 2019), BIA-ALCL typically presents as a late seroma—massive swelling—averaging 7 to 10 years after implantation. If you were treated at a Harris County cancer center and suddenly developed asymmetry or a lump years later, you must seek a biopsy.
Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC)
An even rarer and more aggressive malignancy, BIA-SCC was identified in an MDA safety communication in September 2022. It can occur with both smooth and textured implants. We are monitoring emerging literature for Harris County patients who have been diagnosed with this epithelial tumor.
Red Breast Syndrome and Endotoxin Science
Acellular dermal matrix products can trigger a condition known as Red Breast Syndrome (RBS)—a sterile, non-infectious inflammation where the breast skin appears bright red. Research led by experts like Nguyen et al. (2019) suggests this is caused by bacterial endotoxins (LPS) that survive the sterilization process. Even if the device is technically “sterile,” the endotoxins remain biologically active, triggering a chronic immune response in many Harris County patients.
P4HB Hydrolysis and Scaffold Failure
The failure of GalaFLEX and Phasix to resorb as promised often leads to “bottoming out” or lateral displacement of the breast. When the P4HB hydrolysis kinetics are altered by the host environment, the scaffold can become a rigid, painful foreign body that requires surgical extraction.
If you have experienced skin-flap necrosis, sepsis, or permanent scarring, our associate attorney Lupe Peña—a third-generation Texan who conducts full consultations in fluent Spanish—is ready to advocate for your rights. Call 888-288-9911 today.
Why Your Attorney’s Knowledge of Federal Preemption Matters in Harris County
Device manufacturers frequently try to dismiss cases in the Southern District of Texas by arguing that federal law “preempts” or blocks state-law claims. A generalist personal injury lawyer in Harris County may fall for this trap, but we understand the nuanced doctrinal map.
We focus on “parallel claims”—specifically that the manufacturer violated federal Medical Device Reporting (MDR) requirements under 21 CFR Part 803. If a manufacturer like Becton Dickinson fails to report adverse events or hides breast cancer recurrence data (as alleged by whistleblower Dr. Hooman Noorchashm), they have violated federal law. Under the parallel claim doctrine, Harris County plaintiffs can maintain state-law negligence and strict liability claims that are “identical to, but not different from” federal requirements.
We draw strength from our current lead counsel role in high-stakes litigation like Bermudez v. Pi Kappa Phi, demonstrating our ability to manage complex discovery and multi-defendant institutional liability. Whether your case belongs in the Allergan BIOCELL MDL 2921 before Judge Brian R. Martinotti or in a Harris County state court, we have the federal court admission and the practice tenure (27 years) to fight for you.
The Whistleblower: Dr. Hooman Noorchashm and Becton Dickinson
For Harris County victims of GalaFLEX or Phasix injuries, the record of Dr. Hooman Noorchashm is critical. As a former Medical Director for Becton Dickinson (BD), Dr. Noorchashm became a whistleblower in 2022. He alleged that BD withheld data concerning breast cancer recurrences in GalaFLEX clinical trials and engaged in aggressive off-label marketing to Harris County surgeons.
He specifically pointed to the MAUDE database, noting that manufacturer and user facility device experience reports were often incomplete or minimized patient harm. When a manufacturer hides the truth from the FDA and from Harris County surgeons, they lose the protection of the “Learned Intermediary Doctrine.” This allows us to argue that the failure to warn was a direct result of corporate deception.
Statues of Limitations and the Discovery Rule in Harris County
In Texas, the statute of limitations for a product liability claim is generally two years from the date of the injury. However, for many Harris County women, the harm caused by a defective breast mesh or ADM is not immediately apparent.
This is where the “Discovery Rule” becomes the most important legal protection for Harris County residents. The clock may not start until you discovered—or reasonably should have discovered—both the injury and its connection to the defective device. For many, that discovery only happens when a second-opinion surgeon in the Texas Medical Center identifies the mesh as the culprit, or when the FDA publishes a safety communication, such as the November 2023 letter regarding BD mesh.
Do not assume you are too late. Because every case has unique facts, you should contact us at 1-888-ATTY-911 for a free evaluation of your specific Harris County timeline.
Recovering Damages for Harris County Families
If you have suffered a reconstruction failure or a malignancy, the financial toxicity can be overwhelming. Research shows that a single complication can increase the cost of a Harris County reconstruction by over $7,000 in the first year alone. We fight to recover:
- Economic Damages: Past and future medical expenses, including multiple revision surgeries, explantations, IV antibiotics, and hyperbaric oxygen therapy required at Harris County hospitals.
- Non-Economic Damages: Pain and suffering, emotional distress, and permanent disfigurement. While Texas has certain caps on medical liability, product liability claims against manufacturers often allow for more substantial recovery for the loss of the breast and the resulting psychological trauma.
- Lost Wages: We seek compensation for the time you were unable to work in Harris County while recovering from septic shock or corrective procedures.
- Loss of Consortium: We represent Harris County spouses who have suffered as a result of their partner’s devastating injuries.
Our firm’s reputation—backed by an Avvo 8.2 “Excellent” rating and a Martindale-Hubbell Preeminent 5.0 of 5.0 rating—means we approach your case with the financial and investigative resources required to take on global corporations.
Frequently Asked Questions for Harris County Patients
Is surgical mesh approved by the FDA for breast surgery?
No. As of our most recent update, the FDA has not approved or cleared any surgical mesh product specifically for breast surgery. They are used “off-label” in Harris County procedures, a fact many patients are never told.
How do I find out which brand was used in my Harris County surgery?
You have a legal right to your medical records. You must request a complete “operative report” and “implant log” from the Harris County hospital or surgical center where your procedure took place. Look for the “Unique Device Identifier” (UDI) or implant stickers. If the hospital is uncooperative, we can assist in securing these records.
Can I sue even if I didn’t get cancer?
Yes. While BIA-ALCL is a serious concern, the majority of Harris County mesh and ADM lawsuits involve reconstruction failure, chronic infection, red breast syndrome, and permanent disfigurement. These are significant injuries that warrant compensation.
How much does a Harris County breast mesh lawyer cost?
We operate on a contingency fee basis. This means there is no upfront cost to you. We only get paid if we recover compensation for you. If we don’t win, you don’t owe us an attorney’s fee.
¿Ofrece su oficina consultas en español aquí en Harris County?
Sí. Nuestra abogada asociada, Lupe Peña, habla español con fluidez y realiza consultas completas sin necesidad de intérpretes. Entendemos que es vital hablar de su salud y sus derechos legales en su propio idioma.
Steps to Take Now in Harris County
- Seek Medical Care: If you have redness, swelling, or pain near your reconstruction, visit a specialist in Harris County immediately.
- Request Your Records: Secure the operative reports that name the mesh, ADM, or scaffold used.
- Preserve Evidence: If you undergo a revision surgery in Harris County, ensure that the explanted device and any inflamed tissue are preserved for pathology and legal testing.
- Document Symptoms: Keep a journal of your pain and take photographs of visible complications.
- Consult with Attorney911: Call 1-888-ATTY-911.
We serve all of Harris County, from the heart of Houston to Cypress, Pasadena, and Baytown. Our principal office at 1177 West Loop South, Suite 1600, is conveniently located near the Uptown area of Houston, serving the entire Harris County region.
You are not just a case number to us. We host the Attorney 911 podcast (Apple Podcasts ID 1773141988) and provide educational content on our @Manginellolawfirm YouTube channel because we believe an informed Harris County is a protected Harris County. We have over 470 Birdeye reviews with a 4.9-star average because we treat our clients with the humility and professionalism they deserve.
Past results do not guarantee future outcomes, but our 27 years of practice and our current lead role in major litigation like the Bermudez case prove that we have the stamina for the fight ahead.
Contact The Manginello Law Firm, PLLC today at 1-888-ATTY-911 (1-888-288-9911) for a free, confidential consultation. Let us stand with you in Harris County.
